Biotech firm restructures purchasing as spend soars_2
7 September 2012
Pioneering US biotechnology firm Genentech has begun to restructure procurement in order to handle a 35 per cent increase in its third- party budget.
The programme includes setting up four strategic sourcing teams and eventually hiring 10 more purchasers, according to Clive Heal, senior director of global procurement.
"The challenge is change management, getting people to work differently," said Heal, who moved from insurance giant Prudential in the UK in October and stepped down as chairman-elect of CIPS's...